No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Declining Stock and Decent Financials: Is The Market Wrong About Pacira BioSciences, Inc. (NASDAQ:PCRX)?
Jefferies Maintains Pacira BioSciences(PCRX.US) With Buy Rating, Maintains Target Price $36
Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX)
Pacira BioSciences(PCRX.US) Officer Sells US$143.19K in Common Stock
Pacira BioSciences(PCRX.US) Officer Sells US$114.02K in Common Stock
Pacira BioSciences(PCRX.US) Director Sells US$24,974.4 in Common Stock